Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A dyskeratosis congenita caused by impaired telomere maintenance resulting in short or very short telomeres. The phenotypic spectrum includes individuals with classic dyskeratosis congenita (DC) as well as those with very short telomeres and an isolated physical finding. Classic DC is characterized by a triad of dysplastic nails, lacy reticular pigmentation of the upper chest and/or neck, and oral leukoplakia, although this may not be present in all individuals. People with DC/TBD are at increased risk for progressive bone marrow failure (BMF), myelodysplastic syndrome or acute myelogenous leukemia, solid tumors (usually squamous cell carcinoma of the head/neck or anogenital cancer), and pulmonary fibrosis. Other findings can include eye abnormalities (epiphora, blepharitis, sparse eyelashes, ectropion, entropion, trichiasis), taurodontism, liver disease, gastrointestinal telangiectasias, and avascular necrosis of the hips or shoulders. Additional findings include cerebellar hypoplasia (Hoyeraal Hreidarsson syndrome) and bilateral exudative retinopathy and intracranial calcifications (Revesz syndrome and Coats plus syndrome). Onset and progression of manifestations of DC/TBD vary: at the mild end of the spectrum are those who have only minimal physical findings with normal bone marrow function, and at the severe end are those who have the diagnostic triad and early-onset BMF.
No clinical trials have been registered for dyskeratosis congenita and related telomere biology disorder.
17 publications have been identified in PubMed for dyskeratosis congenita and related telomere biology disorder. Research spans Review / Meta-Analysis (35%), Case Report / Case Series (29%), and Basic Science / Preclinical (18%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 6 | 35% |
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 10:31 PM UTC
Patient case studies |
5 |
29% |
Laboratory research | 3 | 18% |
Disease patterns and progression | 2 | 12% |
Clinical study results | 1 | 6% |
Soni J (2026). [PMID: 41741124](https://pubmed.ncbi.nlm.nih.gov/41741124/). *BMJ Case Rep*. [Case Report / Case Series]
Gibson NM (2026). [PMID: 41956864](https://pubmed.ncbi.nlm.nih.gov/41956864/). *Semin Hematol*. [Case Report / Case Series]
Wedge E (2026). [PMID: 41332233](https://pubmed.ncbi.nlm.nih.gov/41332233/). *Am J Med Genet A*. [Case Report / Case Series]
Longhurst HJ (2026). [PMID: 42110436](https://pubmed.ncbi.nlm.nih.gov/42110436/). *Front Med (Lausanne)*. [Review / Meta-Analysis]
Sande CM (2026). [PMID: 41896073](https://pubmed.ncbi.nlm.nih.gov/41896073/). *Semin Hematol*. [Epidemiology / Natural History]
Asghar N (2025). [PMID: 40634789](https://pubmed.ncbi.nlm.nih.gov/40634789/). *Biochem Genet*. [Basic Science / Preclinical]
Jones-Weinert C (2025). [PMID: 39614014](https://pubmed.ncbi.nlm.nih.gov/39614014/). *Nat Rev Mol Cell Biol*. [Review / Meta-Analysis]
Guerrero-López R (2025). [PMID: 39971959](https://pubmed.ncbi.nlm.nih.gov/39971959/). *Sci Rep*. [Basic Science / Preclinical]
Smoom R (2025). [PMID: 40530700](https://pubmed.ncbi.nlm.nih.gov/40530700/). *Nucleic Acids Res*. [Basic Science / Preclinical]
Yu G (2025). [PMID: 39849589](https://pubmed.ncbi.nlm.nih.gov/39849589/). *J Med Case Rep*. [Case Report / Case Series]